Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Rectal reconstruction after endoscopic submucosal dissection for removal of a giant rectal lesion.

Kantsevoy SV, Wagner A, Mitrakov AA, Thuluvath AJ, Berr F.

VideoGIE. 2019 Jan 31;4(4):179-181. doi: 10.1016/j.vgie.2018.12.001. eCollection 2019 Apr. No abstract available.

2.

Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells.

Wanek J, Gaisberger M, Beyreis M, Mayr C, Helm K, Primavesi F, Jäger T, Di Fazio P, Jakab M, Wagner A, Neureiter D, Kiesslich T.

Int J Mol Sci. 2018 Oct 12;19(10). pii: E3128. doi: 10.3390/ijms19103128.

3.

Endoscopic submucosal dissection (ESD) for anal high-grade intraepithelial neoplasia: a case report.

Wagner A, Neureiter D, Holzinger J, Kiesslich T, Klieser E, Berr F.

Z Gastroenterol. 2018 May;56(5):495-498. doi: 10.1055/a-0578-9059. Epub 2018 May 7.

PMID:
29734448
4.

Single-center implementation of endoscopic submucosal dissection (ESD) in the colorectum: Low recurrence rate after intention-to-treat ESD.

Wagner A, Neureiter D, Kiesslich T, Wolkersdörfer GW, Pleininger T, Mayr C, Dienhart C, Yahagi N, Oyama T, Berr F.

Dig Endosc. 2018 May;30(3):354-363. doi: 10.1111/den.12995. Epub 2018 Jan 3.

PMID:
29218732
5.

The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.

Mayr C, Helm K, Jakab M, Ritter M, Shrestha R, Makaju R, Wagner A, Pichler M, Beyreis M, Staettner S, Jaeger T, Klieser E, Kiesslich T, Neureiter D.

Hum Pathol. 2018 Feb;72:117-126. doi: 10.1016/j.humpath.2017.11.003. Epub 2017 Nov 11.

PMID:
29133140
6.

Reduced complication rates of percutaneous transhepatic biliary drainage with ultrasound guidance.

Wagner A, Mayr C, Kiesslich T, Berr F, Friesenbichler P, Wolkersdörfer GW.

J Clin Ultrasound. 2017 Sep;45(7):400-407. doi: 10.1002/jcu.22461. Epub 2017 Mar 2.

PMID:
28251661
7.

Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism.

Stechemesser L, Eder SK, Wagner A, Patsch W, Feldman A, Strasser M, Auer S, Niederseer D, Huber-Schönauer U, Paulweber B, Zandanell S, Ruhaltinger S, Weghuber D, Haschke-Becher E, Grabmer C, Rohde E, Datz C, Felder TK, Aigner E.

Mol Metab. 2016 Oct 31;6(1):38-47. doi: 10.1016/j.molmet.2016.10.006. eCollection 2017 Jan.

8.

Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers.

Mayr C, Beyreis M, Wagner A, Pichler M, Neureiter D, Kiesslich T.

Biomed Res Int. 2016;2016:4805270. Epub 2016 Nov 9. Review.

9.

Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients.

Urbas R, Mayr C, Klieser E, Fuereder J, Bach D, Stättner S, Primavesi F, Jaeger T, Stanzer S, Ress AL, Löffelberger M, Wagner A, Berr F, Ritter M, Pichler M, Neureiter D, Kiesslich T.

Int J Mol Sci. 2016 Dec 7;17(12). pii: E2053.

10.

The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells.

Mayr C, Wagner A, Loeffelberger M, Bruckner D, Jakab M, Berr F, Di Fazio P, Ocker M, Neureiter D, Pichler M, Kiesslich T.

Oncotarget. 2016 Jan 5;7(1):745-58. doi: 10.18632/oncotarget.6378.

11.

Neoadjuvant Down-Sizing of Hilar Cholangiocarcinoma with Photodynamic Therapy--Long-Term Outcome of a Phase II Pilot Study.

Wagner A, Wiedmann M, Tannapfel A, Mayr C, Kiesslich T, Wolkersdörfer GW, Berr F, Hauss J, Witzigmann H.

Int J Mol Sci. 2015 Nov 6;16(11):26619-28. doi: 10.3390/ijms161125978.

12.

3-Deazaneplanocin A May Directly Target Putative Cancer Stem Cells in Biliary Tract Cancer.

Mayr C, Wagner A, Stoecklinger A, Jakab M, Illig R, Berr F, Pichler M, Di Fazio P, Ocker M, Neureiter D, Kiesslich T.

Anticancer Res. 2015 Sep;35(9):4697-705.

PMID:
26254359
13.

The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.

Mayr C, Wagner A, Neureiter D, Pichler M, Jakab M, Illig R, Berr F, Kiesslich T.

BMC Complement Altern Med. 2015 Jun 23;15:194. doi: 10.1186/s12906-015-0721-5.

14.

Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: A multicenter prospective phase II study.

Wagner A, Denzer UW, Neureiter D, Kiesslich T, Puespoeck A, Rauws EA, Emmanuel K, Degenhardt N, Frick U, Beuers U, Lohse AW, Berr F, Wolkersdörfer GW.

Hepatology. 2015 Nov;62(5):1456-65. doi: 10.1002/hep.27905. Epub 2015 Jul 22.

PMID:
25990106
15.

Cytotoxic effects of chemokine receptor 4 inhibition by AMD3100 in biliary tract cancer cells: Potential drug synergism with gemcitabine.

Mayr C, Neureiter D, Pichler M, Berr F, Wagner A, Kiesslich T, Namberger K.

Mol Med Rep. 2015 Aug;12(2):2247-52. doi: 10.3892/mmr.2015.3589. Epub 2015 Apr 1.

PMID:
25846744
16.

The role of polycomb repressive complexes in biliary tract cancer.

Mayr C, Neureiter D, Wagner A, Pichler M, Kiesslich T.

Expert Opin Ther Targets. 2015 Mar;19(3):363-75. doi: 10.1517/14728222.2014.986460. Epub 2014 Nov 26. Review.

PMID:
25424424
17.

Iron depletion with a novel apheresis system in patients with hemochromatosis.

Grabmer C, Schmid D, Mayer G, Aigner E, Wagner A, Streif D, Schallmoser K, Rohde E.

Transfusion. 2015 May;55(5):996-1000. doi: 10.1111/trf.12949. Epub 2014 Nov 21.

PMID:
25413608
18.

MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines.

Wagner A, Mayr C, Bach D, Illig R, Plaetzer K, Berr F, Pichler M, Neureiter D, Kiesslich T.

Int J Mol Sci. 2014 Nov 5;15(11):20134-57. doi: 10.3390/ijms151120134.

19.

Real-time analysis of endogenous protoporphyrin IX fluorescence from δ-aminolevulinic acid and its derivatives reveals distinct time- and dose-dependent characteristics in vitro.

Kiesslich T, Helander L, Illig R, Oberdanner C, Wagner A, Lettner H, Jakab M, Plaetzer K.

J Biomed Opt. 2014 Aug;19(8):085007. doi: 10.1117/1.JBO.19.8.085007.

20.

Activated hedgehog pathway is a potential target for pharmacological intervention in biliary tract cancer.

Kiesslich T, Mayr C, Wachter J, Bach D, Fuereder J, Wagner A, Alinger B, Pichler M, Di Fazio P, Ocker M, Berr F, Neureiter D.

Mol Cell Biochem. 2014 Nov;396(1-2):257-68. doi: 10.1007/s11010-014-2161-9. Epub 2014 Jul 27.

PMID:
25064451

Supplemental Content

Loading ...
Support Center